Wednesday, April 17, 2013

Washington Post Barrage

In what can only be called a barrage, the Washington Post trained its guns on the Myriad case and gene patents.  The shock and awe campaign's opening salvo was an Op Ed piece  titled "Who owns your DNA? Not who you think." in the print edition, and more directly on line as "The Supreme Court should invalidate the patent on human DNA." Jeffrey Rosenfeld and Christopher Mason, holding PhD's from NYU and Yale, respectively, who are professors of genomics at New Jersey and Cornell Medical Schools, respectively. were the authors.  They conclude, "It is imperative that the Supreme Court invalidate Myriad’s patent, defend genomic liberty and make clear that one’s genes belong to that person alone."
Then, in an editorial timed to coincide with the oral arguments in the case on April 15, 2013, the Post fired, "Patents on Human DNA need Congress's input."
The next day, two thirds of A2 rang out with commentary by Dana Milbank and straight reportage by Robert Barnes.  I have only one comment to make, and it's addressed to Dana Milbank: While I agree with your conclusion wholeheartedly, shame on you for making fun of Justice Sotomayor - we need the vote!

Sunday, April 14, 2013

Interesting Poll:

In anticipation of the Myriad hearing tomorrow the IPO (see pages 69-72 of my book "Other Peoples Bodies.") is having a webinar on the case on Wednesday, April 17.  On the panel will be be our own, Prof. Joshua Sarnoff, along with two bio-patent techies.
A previous webinar was held on the Prometheus case, in which the SCOTUS unanimously struck down a patent on so-called "personalized medicine."  The Myriad and Prometheus cases are closely linked.
In the wake of the previous webinar, the guiding hand behind it, Pamela Sherrid, conducted a poll with some not so surprising results: 75% of the patent professionals responding said the SCOTUS got the law wrong; 66% said they could get around the decision by clever claim drafting.  Finally, the poll asked several questions about the Myriad case.  Here's the surprise: 44% said the decision would be the same, with 41% saying the Court would take the DOJ position (See page 57 of "OPB") and, not surprisingly, only 15% saying all claims would be invalidated.  The poll is located at:
http://ipchat.biz/prometheuspoll.html

Friday, February 22, 2013

ALDF Revisited



A new opportunity has arisen to overturn ALDF v Quigg, the case testing the validity of  patents on all non-human animals.
Prolume v Gentarget et al.is outlined below:
Infringement
Court : U.S. District Court for the Southern District of California
Presided by: William Q. Hayes
Civil Action No: 3:13-cv-00130-WQH-BLM
Defendant(s) :
1. Gentarget, Inc.
2. Genprice, Inc.
3. Amsbio LLC
4. BST Scientific PTE LTD
5. Gentaur Molecular Products BVBA
6. Filgen Biosciences, Inc.
7. Does 1 through 10, Inclusive
Plaintiff(s) :
Prolume, LTD. — represented by
Law Offices of Philip J Kaplan; Los Angeles, CA
Attorneys: Philip Jeremy Kaplan
Patent(s) in Suit :

6,232,107
conduct.png
Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent
by Bryan et. al.
7,109,315
conduct.png
Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins
by Bryan et. al.

The lawsuit reeks of the the "indicia of extortion."
Additionally since the patents claim animal genes (aquatic life) a defense might be the invalidity of patents for the reasons argued by ALDF against then-Commissioner Donald Quigg, supporting the Patent Office.  For details see the post on my blog: (http://www.koshergoldfish.com/ethics_of_biotechnology.html)
"Other Peoples Bodies."




GenTarget Inc, 6640 Lusk Blvd. Suite A107, San Diego, USA(858)678-8683

Tuesday, February 19, 2013

Interesting SCOTUS Blog post

http://www.scotusblog.com/2013/02/nothing-under-the-sun-that-is-made-of-man/

The author concludes:

" In any case, if the law’s prior treatment of human-related inventions is a reliable guide, it is likely that human gene patents will soon be history."

Watson Brief before the Supreme Court

http://www.wileyrein.com/newsroom.cfm?sp=newsreleases&id=810

The brief is at the end of the article.

Oral Argument set for Monday, April 15, 2013


     

No. 12-398
Title:
Association for Molecular Pathology, et al., Petitioners
v.
Myriad Genetics, Inc., et al.
Docketed:October 1, 2012
Lower Ct:United States Court of Appeals for the Federal Circuit
  Case Nos.:(2010-1406)
  Decision Date:August 16, 2012
Questions Presented

~~~Date~~~ ~~~~~~~Proceedings  and  Orders~~~~~~~~~~~~~~~~~~~~~
Sep 25 2012Petition for a writ of certiorari filed. (Response due October 31, 2012)
Oct 3 2012Consent to the filing of amicus curiae briefs, in support of either party or of neither party, received from counsel for the petitioners.
Oct 24 2012Brief amici curiae of National Women's Health Network, et al filed.
Oct 26 2012Brief amicus curiae of Academics in Law, Medicine, Health Policy and Clinical Genetics filed.
Oct 30 2012Brief amicus curiae of AARP filed.
Oct 30 2012Brief amici curiae of Cancer Council Australia, et al. filed.
Oct 31 2012Brief of respondents Myriad Genetics, Inc., et al. in opposition filed.
Oct 31 2012Brief amici curiae of Kali N. Murray and Erika R. George filed.
Oct 31 2012Brief amici curiae of Canavan Foundation, et al. filed.
Oct 31 2012Brief amici curiae of American Medical Association, et al. filed.
Nov 9 2012Reply of petitioners Association for Molecular Pathology, et al. filed.
Nov 13 2012DISTRIBUTED for Conference of November 30, 2012.
Nov 30 2012Petition GRANTED limited to Question 1 presented by the petition.
Jan 2 2013Consent to the filing of amicus curiae briefs, in support of either party or of neither party, received from counsel for the petitioners.
Jan 3 2013The time to file the joint appendix and petitioners' brief on the merits is extended to and including January 24, 2013.
Jan 3 2013The time to file respondents' brief on the merits is extended to and including March 7, 2013.
Jan 24 2013Joint appendix filed. (2 volumes)
Jan 24 2013Brief of petitioners Association for Molecular Pathology, et al. filed.
Jan 28 2013Brief amicus curiae of Juhasz Law Firm, P.C. in support of neither party filed.
Jan 29 2013Brief amici curiae of American Medical Association, et al. filed.
Jan 30 2013Brief amici curiae of GeneDx and Law Professors filed.
Jan 30 2013Brief amici curiae of National Women's Health Network, et al. filed.
Jan 30 2013Brief amicus curiae of Federation Internationale Des Conseils En Propriete Intellectuelle in support of neither party filed.
Jan 31 2013Brief amicus curiae of CLS Bank International in support of neither party filed.
Jan 31 2013Brief amicus curiae of United States in support of neither party filed.
Jan 31 2013Brief amici curiae of International Center for Technology Assessment, et al. filed.
Jan 31 2013Brief amicus curiae of Genformatic LLC filed.
Jan 31 2013Brief amici curiae of Academics in Law, Medicine, Health Policy and Clinical Genetics in support of neither party filed.
Jan 31 2013Brief amicus curiae of James D. Watson, Ph.D. in support of neither party filed.
Jan 31 2013Brief amici curiae of Fifteen Law professors filed.
Jan 31 2013Brief amicus curiae of Sigram Schindler Beteiligungsgesellschaft mbH in support of neither party filed.
Jan 31 2013Brief amicus curiae of AARP filed.
Jan 31 2013Brief amici curiae of Kali N. Murray and Erika R. George filed.
Jan 31 2013Brief amicus curiae of Institute of Professional Representatives Before the European Patent Office (EPI) in support of neither party filed.
Jan 31 2013Brief amici curiae of Ethics & Religious Liberty Commission of the Southern Baptist Convention and Prof. D. Brian Scarnecchia filed.
Jan 31 2013Brief amicus curiae of Eric S. Lander in support of neither party filed.
Jan 31 2013Brief amicus curiae of American Intellectual Property Law Association in support of neither party filed.
Jan 31 2013Brief amici curiae of Canavan Foundation, et al. filed.
Jan 31 2013Brief amicus curiae of Professor Eileen M. Kane filed.
Jan 31 2013Brief amicus curiae of Knowledge Ecology International filed.
Jan 31 2013Brief amicus curiae of InVitae Corporation filed.
Feb 11 2013SET FOR ARGUMENT ON Monday, April 15, 2013
Feb 14 2013CIRCULATED